Researchers are conducting studies to help understand how diabetes drugs affect glucose excretion, the gut microbiome, and their metabolic products.

After an illustrious career, including 12 years as director of the NIH and leading the HGP consortium, Francis Collins announces his sudden resignation.

Genomics technologies, while powerful, are not sufficient to bring precision medicine into routine clinical practice.

The addition of Solventum’s business provides a strategic fit with Thermo Fisher and will create value for customers, ...

Successful research in targeted protein degradation depends not only on measurements at high sensitivity, speed and precision ...

At the four new sites, Lilly expects to create more than 3,000 jobs for engineers, scientists, operations personnel, and lab ...

Study findings provide insights into the biological underpinnings linking heat to aging-related morbidity and mortality risks ...

Eikon is pursuing a number of clinical-stage programs including EIK1001, which is currently in Phase III testing for advanced ...

The AGBT meeting has begun in Marco Island, Florida and Julianna LeMieux is on the ground. Here, she shares the latest news ...

The scientists found that HSV-1 activates transposable elements that impact the accumulation of Alzheimer's-linked proteins ...

Recombinase efficiency increases allow Qi Biodesign to insert 20-30 kb (5 or 6 genes) at one time at one location across a variety of different crop genetics. In addition, a large team at Qi Biodesign ...

1. Characterization of lipid components in lipid nanoparticle (LNP) formulations – Application Note AN001928 – an-001928-bt-lipid-components-LNP-an001928-na-en.pdf (SECURED) ...